Bioactive plant peptides shown to reduce inflammation and stimulate mitochondria
Valogen has developed a versatile technology to create bioactive peptides from low-cost, sustainable and proteinaceous agri-food by-products to support the circular economy. The bioavailability of bioactive oligopeptides offers a unique avenue for enhancing human health. It is estimated that ~40% of weight loss due to GLP1s could be from muscle loss. The GLP1 nutritional support market is projected to grow from $4.1Bn in 2025 to $13Bn by 2035 representing a CAGR of 12.2%. Our protein hydrolysate has been shown in in vitro studies with a University bioenergetics group to stimulate muscle cell mitochondrial expression of ATP in a dose-dependent fashion even in the absence of an energy demand (i.e. exercise) aligning it as a potential exercise-mimetic with very strong potential to support weight loss programmes.
We have demonstrated that the protein synthesis rate of human myotubes is raised dose-dependently by our ingredient. Enhanced energy demand from anabolic stimulation increases overall ATP supply, a bioenergetic stimulation that likely relates mechanistically to anabolic hormonal effects provoked by insulin. Strikingly, leucine exposure revealed that the anabolic stimulation induced by the Valogen material is far more pronounced than that seen with branched-chain amino acids.
We have demonstrated that the protein synthesis rate of human myotubes is raised dose-dependently by our ingredient and more strongly than leucine. Enhanced energy demand from anabolic stimulation increases overall ATP supply, a bioenergetic stimulation that likely relates mechanistically to anabolic hormonal effects provoked by insulin.
Proteins provide challenges for food formulation due to their poor solubility, often poor mouthfeel and tendency to denature further decreasing their solubility and food format compatibility. Our protein hydrolysate (oligopeptide) ingredient is thermally stable and highly soluble over a wide pH range.
About Valogen Biosciences Ltd
Valogen Biosciences Ltd is an agritech company that transforms underutilised agri-food side-streams, such as rapeseed meal, into high-value bioactive peptides. The company employs a proprietary, scalable process—developed through extensive research and pilot plant operations—to extract and purify these materials. Their technology allows for the creation of functional ingredients that serve as alternatives to traditional, lower-value applications of agricultural by-products, focusing on delivering scientifically validated, highly digestible, and allergen-free components. By leveraging circular economy principles, the company aims to convert waste streams into sustainable, high-value biorenewables.
The company provides innovative solutions for the nutrition, personal care, and medical sectors. Their bioactive peptides have demonstrated efficacy in various applications, including as hair conditioners in cosmetics, savoury flavour enhancers in food products, and agents with anti-inflammatory and wound-healing properties in healthcare. Valogen works with industrial partners and research institutions to validate their products and scale production, having progressed from laboratory concepts to functional pilot-scale manufacturing. Their business strategy relies on continuous R&D, strategic grants, and partnerships to support their transition toward larger, commercial-scale production facilities.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.